ANN ARBOR

Washtenaw Community College, Central State University sign HBCU transfer partnership; HBCU Day hosts 400+ high school students

Retrieved on: 
星期五, 五月 3, 2024
Education, Central State, Community college, WCC, School, Ypsilanti Community Schools, Dream, George Taylor Field, Humanities, Partnership, Social, Engineering, Vocational education, Mathematics, Science, Access, Enrollment, Central State University, Wilberforce University, Student, HBCU, Marching band, Tutoring

WCC President Dr. Rose B. Bellanca welcomed Central State University guests and community leaders at the signing ceremony.

Key Points: 
  • WCC President Dr. Rose B. Bellanca welcomed Central State University guests and community leaders at the signing ceremony.
  • Dr. Arletha McSwain, Vice Provost of Access & Enrollment Management representing Central State University’s Interim President, Dr. Alex Johnson, signed the partnership agreement.
  • Located in Wilberforce, Ohio, Central State boasts a storied heritage with its roots beginning at Wilberforce University, the oldest private HBCU in the nation.
  • Today’s HBCU Day will culminate in a Central State University Marching Band performance and a “Divine Nine Fraternity & Sorority Stroll Off” in the Community Park on WCC’s campus.

The Coretec Group Announces a Full Utility Patent Filing and Provides an Update on the Definitive Share Exchange Agreement with Core Optics

Retrieved on: 
星期四, 五月 2, 2024
CHS, EVS, PCAOB, OTCQB, ANN, Silicon, Engineering, Patent

On May 1, 2024, The Coretec Group filed its full utility patent application for Endurion after filing its provisional patent application in May 2023.

Key Points: 
  • On May 1, 2024, The Coretec Group filed its full utility patent application for Endurion after filing its provisional patent application in May 2023.
  • TAAD is highly qualified in this space, working directly with public companies including those with business operations in Asia.
  • The corporate headcount has also grown, predominantly in manufacturing and engineering, to meet the demand and work through its backlog.
  • The process for this share exchange will take time, and we are appreciative of the patience from employees, partners and especially our shareholders.”

Esperion to Report First Quarter 2024 Financial Results on May 7

Retrieved on: 
星期二, 四月 23, 2024
ANN, Health, Esperies, ESPR, PIN, Patient, Risk

ANN ARBOR, Mich., April 23, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024.

Key Points: 
  • ANN ARBOR, Mich., April 23, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024.
  • ET to discuss these financial results and provide business updates.
  • Please click here to pre-register to participate in the conference call and obtain your dial in number and PIN.
  • A live audio webcast can be accessed on the investor and media section of the Esperion website at esperion.com/investor-relations/events .

Movellus Extends Droop Management Leadership with Aeonic Generate™ AWM3

Retrieved on: 
星期二, 四月 16, 2024
Siemens Digital Industries Software, DVFS, IP, Risk, EMIR, AI, Voltage droop, Silicon, ICS, Digital, Paramount, PDN, Electromigration, PLL, Socs, Video game

SUNNYVALE, Calif., April 16, 2024 (GLOBE NEWSWIRE) --  Movellus today announced the expansion of its award-winning1 droop response solutions with the Aeonic Generate™ AWM3.

Key Points: 
  • SUNNYVALE, Calif., April 16, 2024 (GLOBE NEWSWIRE) --  Movellus today announced the expansion of its award-winning1 droop response solutions with the Aeonic Generate™ AWM3.
  • In combination, the AWM3 droop mitigation and dynamic frequency scaling capabilities reduce the power consumption of complex integrated circuits (ICs) while maintaining the device’s operational integrity.
  • In combination with the Aeonic Insight™ Droop Detector, the AWM3 provides the industry’s only complete droop detection and response system that also provides insight into droop profiles and clock metrics that can be leveraged by silicon analytics platforms.
  • “Active droop management is just what these customers need to manage dynamic voltage droop excursions in-situ and minimize risk of escapes.”
    Key features of the Aeonic Generate AWM3 include:
    Movellus continues to advance high-performance silicon through feature-rich, synthesizable IP.

LEAD Prep Academy, Washtenaw Community College sign multi-year agreement to educate student-athletes

Retrieved on: 
星期一, 四月 15, 2024
Education, Washtenaw Community College, Football, TIP, NIL, Provost, ANN, WCC, Male, Partnership, Washtenaw, University, Female, Engineering, Athlete, HLC, Student, NCAA, Nursing

ANN ARBOR, Mich., April 15, 2024 (GLOBE NEWSWIRE) -- Washtenaw Community College (WCC) and LEAD Prep Academy have signed a multi-year agreement for WCC to become the preferred educational partner of LEAD Prep Academy.

Key Points: 
  • ANN ARBOR, Mich., April 15, 2024 (GLOBE NEWSWIRE) -- Washtenaw Community College (WCC) and LEAD Prep Academy have signed a multi-year agreement for WCC to become the preferred educational partner of LEAD Prep Academy.
  • LEAD Prep Academy, powered by the L.E.A.D Foundation and the Legacy Center Sports Complex, will open in May at the state-of-the-art sports complex in Brighton, 15 minutes north of the Washtenaw Community College campus in Ann Arbor.
  • Student-athletes at LEAD Prep Academy will enroll as Washtenaw Community College students, earning college credits, on track to graduate with their associate degree in 20 months, with the ultimate goal of transferring to a four-year college or university with NCAA athletic programs.
  • LEAD Prep Academy student-athletes will compete in a full national schedule against other junior college and post-graduate athletic programs.

DocNetwork Completes SOC 2 Type 1 and HIPAA Certifications for CampDoc and SchoolDoc Platforms

Retrieved on: 
星期三, 四月 10, 2024
Organization, HIPAA, Accountability Act, Safety, PII, ANN, School, Health, SOC 2, PHI, Privacy, SOC, Protected health information, Trust, Confidentiality, Student, Audit

ANN ARBOR, Mich., April 10, 2024 (GLOBE NEWSWIRE) -- DocNetwork announced that it has successfully completed both the SOC 2 Type 1 audit and HIPAA audit for its CampDoc and SchoolDoc platforms.

Key Points: 
  • ANN ARBOR, Mich., April 10, 2024 (GLOBE NEWSWIRE) -- DocNetwork announced that it has successfully completed both the SOC 2 Type 1 audit and HIPAA audit for its CampDoc and SchoolDoc platforms.
  • DocNetwork’s independent validation of security controls is crucial to ensure that the Personal Identifiable Information (PII) and Protected Health Information (PHI) for campers, students, and staff is protected.
  • Successful completion of the SOC 2 Type I and HIPAA audits demonstrates a major milestone for the company, and DocNetwork has already started their SOC 2 Type II audit.
  • CampDoc and SchoolDoc offer the most comprehensive solution to help ensure the health and safety of children while they are away from home, and trusted by over 1,250 programs across all 50 states and internationally.

Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity

Retrieved on: 
星期日, 四月 7, 2024
Uric acid, Urinary tract infection, Anaphylaxis, Myocardial infarction, Common, Bronchitis, Patient, Atherosclerosis, FAHA, Cleveland Clinic, Bempedoic acid, Ezetimibe, Therapy, Anemia, Pain, MACE, Sinusitis, ACC, FOMA, FNLA, FACC, Obesity, Cardiovascular disease, Esperion Therapeutics, Abdominal pain, Risk, Gout, Spasm, Woman, American College, Body mass index, ESPR, Back pain, Outcome, ATP, Safety, Fatigue, Arthralgia, ANN, Angioedema, Kidney, Journal, Constipation, University, Adverse event, Pregnancy, CLEAR, Rash, MPH, Rupture, FDA, Molina Healthcare, JACC, Hypersensitivity, Health, Circulatory system, Tablet, CVD, Incidence, Diarrhea, Fetus, Gallstone, Diet, Excipient, Upper respiratory tract infection, Dietary supplement

ANN ARBOR, Mich., April 07, 2024 (GLOBE NEWSWIRE) -- Esperion (Nasdaq: ESPR) today announced the presentation of results from three pre-specified subgroups from CLEAR Outcomes at the 2024 American College of Cardiology’s Annual Scientific Sessions (ACC.24): women, Hispanic/Latinx, and patients with obesity. These results align with the American College of Cardiology’s robust diversity, equity and inclusion programs to drive cultural change across the profession and ensure that the cardiovascular care team is as diverse as the patients they care for and that all patients are represented in cardiovascular research. The data also reinforce the mission of the ACC: transforming cardiovascular care for all.

Key Points: 
  • “Bempedoic acid is the only FDA approved non-statin LDL lowering therapy to demonstrate reductions in MACE in both primary prevention and secondary prevention patient populations.
  • The Hispanic population is the largest ethnic minority in the U.S., yet is a population historically underrepresented in clinical trials.
  • At Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases.
  • CLEAR Outcomes is part of the CLEAR clinical research program for NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) Tablet.

NCMS to Hold Meeting for Technology Innovators Seeking DOD Maintenance and Sustainment Business

Retrieved on: 
星期二, 四月 2, 2024
CTMA, Education, DOD, Government

Ann Arbor, MI, April 02, 2024 (GLOBE NEWSWIRE) -- Technology innovators seeking to learn more about the Department of Defense’s (DOD’s) maintenance and sustainment needs should register for the upcoming Commercial Technologies for Maintenance Activities (CTMA) Partners Meeting.

Key Points: 
  • Ann Arbor, MI, April 02, 2024 (GLOBE NEWSWIRE) -- Technology innovators seeking to learn more about the Department of Defense’s (DOD’s) maintenance and sustainment needs should register for the upcoming Commercial Technologies for Maintenance Activities (CTMA) Partners Meeting.
  • The National Center for Manufacturing Sciences (NCMS) is hosting the event, which is scheduled for May 7-9, 2024, at the Graduate Providence in Providence, RI.
  • The CTMA Partners Meeting is designed to promote an exchange of best practices and technology solutions among maintenance and sustainment leaders in government, industry, and academia.
  • This event is the only DOD-wide forum dedicated to advancing maintenance and sustainment (M&S) capabilities, where the primary focus is on innovations and ideas that drive the evolution of M&S strategies.

Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024

Retrieved on: 
星期一, 四月 1, 2024
Health, ANN, Risk, Patient, Esperies, ESPR, FDA, Food, Pharmaceutical industry

ANN ARBOR, Mich., April 01, 2024 (GLOBE NEWSWIRE) -- Esperion (Nasdaq: ESPR) today announced that Sheldon Koenig, President and CEO, will ring the Nasdaq Stock Market (Nasdaq) opening bell at 9:30 a.m.

Key Points: 
  • ANN ARBOR, Mich., April 01, 2024 (GLOBE NEWSWIRE) -- Esperion (Nasdaq: ESPR) today announced that Sheldon Koenig, President and CEO, will ring the Nasdaq Stock Market (Nasdaq) opening bell at 9:30 a.m.
  • ET today, April 1, 2024, to commemorate the U.S. Food and Drug Administration’s (FDA) recent approval of broad new labels for Esperion’s products.
  • “We are honored to ring the Nasdaq opening bell to celebrate a significant milestone for Esperion,” said Mr. Koenig.
  • At Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases.

Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference

Retrieved on: 
星期二, 三月 26, 2024
Risk, Health, Patient, ANN, Conference, Esperies, ESPR, Broadcasting

ANN ARBOR, Mich., March 26, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced its participation in the 23rd Annual Needham Virtual Healthcare Conference.

Key Points: 
  • ANN ARBOR, Mich., March 26, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced its participation in the 23rd Annual Needham Virtual Healthcare Conference.
  • Sheldon Koenig, President and CEO, will participate in a fireside chat on Tuesday, April 9, 2024, at 12:45 PM ET.
  • The Esperion management team will also host investor meetings that same day.
  • A live audio webcast can be accessed on the investor and media section of the Esperion website .